WORK Medical Technology Group LTD - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of December 2025 for WORK Medical Technology Group LTD, a foreign private issuer headquartered in Hangzhou, China. The report details a significant corporate action: a 100:1 consolidation of ordinary shares effective December 29, 2025.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on capital structure changes.
Material Changes
- Share Consolidation: Implemented a 100:1 consolidation of all authorized, issued, and outstanding shares to meet Nasdaq minimum bid price requirements (Listing Rule 5550(a)(2)) and avoid delisting.
- Capitalization Adjustment: Pre-consolidation outstanding shares were 122,001,406. Post-consolidation outstanding shares are approximately 1,220,015 (1,219,255 Class A and 760 Class B).
- Authorized Shares: Authorized share capital is now US$100,000,000, divided into 16,000,000 Class A and 4,000,000 Class B ordinary shares, each with a par value of US$5.00.
- Trading Details: Shares began trading on a post-consolidation basis on December 29, 2025, under the symbol "WOK" with a new CUSIP number G9767H125.
- Fractional Shares: Fractional shares resulting from the consolidation were rounded up to the nearest whole number.
Guidance, Outlook, and Risks
Management commentary indicates the primary driver for this action was compliance with Nasdaq listing standards to mitigate delisting risk. The filing does not contain forward-looking guidance on revenue or earnings, nor does it detail other operational risks or contingencies beyond the immediate listing status.
Investor Verification Checklist
- Verify the new CUSIP number (G9767H125) for accurate trading and record-keeping.
- Confirm the adjusted share count in brokerage accounts, noting the rounding up of fractional shares.
- Monitor the stock's bid price to ensure continued compliance with Nasdaq Listing Rule 5550(a)(2).
- Review the amended and restated memorandum of association for updated governance terms.